Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

25% of patients non-adherent to antihypertensive treatment

  • Print
  • Comment
  • Save

25% of patients being treated with antihypertensives are non-adherent to treatment, shows a recent UK study.

A total of 208 hypertensive patients – 125 of which were new referrals from primary care – underwent screening of antihypertensive drug intake at a blood pressure centre in Leicester, using high performance liquid chromatography-tandem mass spectrometry urine analysis at the time of their first appointment. Evaluation included screening for 40 of the most commonly prescribed antihypertensive medications, including ramipril and lisinopril.

Overall, 25% of patients were either totally or partially non-adherent to antihypertensive treatment (total non-adherence 10.1%, partial non-adherence 14.9%). Of those referred from primary care, 18.4% were found to have any of the two non-adherence criteria, with an average number of screened medications lower than the average number prescribed.

The researchers noted that their results highlighted that a ‘significant proportion of patients in a specialist centre show at least some degree of treatment non-adherence and that their blood pressure levels correlate well with the degree of non-adherence’.

Read more here

Have your say

  • Print
  • Comment
  • Save